AB Cube SafetyEasy logo

AB Cube SafetyEasy

by AB Cubeab-cube.com
VISIT OFFICIAL WEBSITE →

OVERVIEW

An AI-powered, cloud-based multivigilance solution for pharmacovigilance, medical device safety, cosmetovigilance, and nutrivigilance, trusted by global life science organizations.

SafetyEasy® Suite by AB Cube is a comprehensive, cloud-based multivigilance management solution designed to streamline global safety operations and ensure regulatory compliance across multiple product types.

As a pioneer of SaaS vigilance applications since 2006, the platform offers a unified database for pharmacovigilance (PV), medical device vigilance (Materiovigilance), cosmetovigilance (CosmEthics®), and nutrivigilance, allowing for the management of complex cases like combination product reporting within a single application.

Key Features & Capabilities:

  • AI-Powered Automation: The AB Cube Galaxy modules, including CasEasy AI (Natural Language Processing for case creation) and Converter (OCR for form data extraction), reduce manual effort and accelerate case intake by up to 70%.
  • Regulatory Compliance: The system is fully compliant with global standards, including ICH E2B (R3), FDA 21 CFR Part 11, and GAMP 5, with automatic system updates to stay current with the latest regulations.
  • Accelerated Reporting: Features like the Reportability Matrix and one-click submission through a dedicated gateway streamline the generation and submission of regulatory reports (e.g., CIOMS I, MedWatch, PBRER, PSUR).
  • Data Management: Includes inbuilt MedDRA and WHO Drug Dictionary (WHODD) coding, signal detection modules (PPR, ROR, Qualitative), and a customizable workflow.

Target Users & Benefits: SafetyEasy® Suite is utilized by Marketing Authorization Holders (MAHs), pharmaceutical laboratories, Contract Research Organizations (CROs), and health authorities worldwide. It is positioned as a cost-effective, agile, and fully validated solution that offers lightning-quick data migration and a typical 'go-live' time of two weeks.

RATING & STATS

Customers
2000+ users
Founded
2006

KEY FEATURES

  • Multivigilance (PV, MD, Cosmo, Nutri)
  • ICH E2B (R3) & E2B (R2) Compliance
  • AI-powered Case Intake (CasEasy AI/NLP)
  • Automated Regulatory Reporting (Reportability Matrix)
  • Signal Detection Modules (PPR, ROR)
  • Dedicated API (SafetyEasy Connect)
  • Inbuilt MedDRA & WHO Drug Dictionary Coding
  • Customizable Workflow Management

PRICING

Model: enterprise
Pricing is based on an enterprise subscription model and is not publicly disclosed. The company promotes the solution as a 'most cost-effective' option with 'full price transparency' and 'no hidden costs.'

TECHNICAL DETAILS

Deployment: saas, cloud, on_premise
Platforms: web
🔌 API Available

USE CASES

Global Pharmacovigilance ManagementMedical Device Adverse Event ReportingCosmetovigilance and Nutrivigilance ComplianceCombination Product Safety ReportingRegulatory Submission to FDA, EMA, MHRA

INTEGRATIONS

eCRF SystemsMedInfo SystemsCRM SystemsBusiness Intelligence Tools (Qlik Sense)WHO Drug Dictionary (WHODD)XEVMPD/IDMPEudraCT

COMPLIANCE & SECURITY

Compliance:
FDA 21 CFR Part 11GAMP 5ICH E2B (R3)GDPREudralex Annex 11HIPAA-compliant hosting (HDS)ISO 27001 data Center
Security Features:
  • 🔒WAF (Web Application Firewall)
  • 🔒Annual Software Security Audits
  • 🔒Quarterly Vulnerability Scans
  • 🔒Data Confidentiality and Integrity
  • 🔒High Availability & Business Continuity Plan

SUPPORT & IMPLEMENTATION

Support: email, phone, dedicated support team
Implementation Time: 1-4 weeks
Target Company Size: small, medium, enterprise
TRAINING AVAILABLE

PROS & CONS

✓ Pros:
  • +Unified platform for all multivigilance (PV, MD, Cosmetic, Nutri) reduces complexity.
  • +Advanced AI/Automation (CasEasy AI, Converter) significantly speeds up case intake.
  • +Full and native ICH E2B(R3) compliance, minimizing validation effort.
  • +Fast implementation ('Go-live in 2 weeks') and quick data migration.
  • +Cost-effective solution compared to legacy enterprise systems.
✗ Cons:
  • -Specific pricing is not publicly available (Enterprise model).
  • -Fewer public reviews/social proof compared to major competitors (e.g., Oracle Argus).
  • -Primary focus is on vigilance; may require integration for full eClinical suite functionality.

ABOUT AB CUBE